4Zhanel GG.Influence of pharmacokinetic and pharmacodynamic principle on antibiotics selection[J].Curr Infect Dis Rep,2001,3(1):29-34.
5Workman P.How much gets there and what does it do? The need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and development[J].Curr Pharm Design,2003,9(11):891-902.
7Baidwin DR,Wise R,Andrews JM,et al.Azithromycin concentrations at the sites of pulmonary infection[J].Eur Respir J,1990,3:886-890.
8Ramadan MA,Tawfik AF,Shibl AM,et al.Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis[J].J Med Microbiol,1995,42:362-366.
9American Thoracic Society Documents.Guidelines for the management of adults with hospital-acquired,ventilator-associated,and healthcare-associated pneumonia[J].Am J Respir Crit Care Med,2005,171 (4):388-416.
10Sandiumenge A,Diaz E,Bodi M,et al.Therapy of ventilator-associated pneumonia:a patient-based approach based on the ten rules of The Tarragona Strategy[J].Intens Care Med,2003,29:876-883.
